These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. In vitro prevention of Pseudomonas aeruginosa early biofilm formation with antibiotics used in cystic fibrosis patients. Fernández-Olmos A; García-Castillo M; Maiz L; Lamas A; Baquero F; Cantón R Int J Antimicrob Agents; 2012 Aug; 40(2):173-6. PubMed ID: 22727530 [TBL] [Abstract][Full Text] [Related]
10. In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection. Hengzhuang W; Wu H; Ciofu O; Song Z; Høiby N Antimicrob Agents Chemother; 2012 May; 56(5):2683-90. PubMed ID: 22354300 [TBL] [Abstract][Full Text] [Related]
11. Dry powder inhalation containing muco-inert ciprofloxacin and colistin co-loaded liposomes for pulmonary P. Aeruginosa biofilm eradication. Wang J; Guo Y; Lu W; Liu X; Zhang J; Sun J; Chai G Int J Pharm; 2024 Jun; 658():124208. PubMed ID: 38723731 [TBL] [Abstract][Full Text] [Related]
12. In vitro efficacy of ciprofloxacin and gentamicin against a biofilm of Pseudomonas aeruginosa and its free-living forms. Agarwal G; Kapil A; Kabra SK; Das BK; Dwivedi SN Natl Med J India; 2005; 18(4):184-6. PubMed ID: 16252547 [TBL] [Abstract][Full Text] [Related]
13. Disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate lyase enhances pathogen eradication by antibiotics. Daboor SM; Rohde JR; Cheng Z J Cyst Fibros; 2021 Mar; 20(2):264-270. PubMed ID: 32482592 [TBL] [Abstract][Full Text] [Related]
14. Tan JH; Vidaillac C; Yam JKH; Chua SL; Givskov M; Yang L Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461320 [TBL] [Abstract][Full Text] [Related]
15. Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm model. Lora-Tamayo J; Murillo O; Bergen PJ; Nation RL; Poudyal A; Luo X; Yu HY; Ariza J; Li J J Antimicrob Chemother; 2014 Sep; 69(9):2434-42. PubMed ID: 24833752 [TBL] [Abstract][Full Text] [Related]
16. Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor. Furiga A; Lajoie B; El Hage S; Baziard G; Roques C Antimicrob Agents Chemother; 2015 Dec; 60(3):1676-86. PubMed ID: 26711774 [TBL] [Abstract][Full Text] [Related]
17. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections. Saini H; Chhibber S; Harjai K Int J Antimicrob Agents; 2015 Apr; 45(4):359-67. PubMed ID: 25604277 [TBL] [Abstract][Full Text] [Related]
18. Polyguluronate simulations shed light onto the therapeutic action of OligoG CF-5/20. Hills OJ; Yong CW; Scott AJ; Smith J; Chappell HF Bioorg Med Chem; 2022 Oct; 72():116945. PubMed ID: 36037625 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo activity of EDTA and antibacterial agents against the biofilm of mucoid Pseudomonas aeruginosa. Liu Z; Lin Y; Lu Q; Li F; Yu J; Wang Z; He Y; Song C Infection; 2017 Feb; 45(1):23-31. PubMed ID: 27189338 [TBL] [Abstract][Full Text] [Related]
20. Selective labelling and eradication of antibiotic-tolerant bacterial populations in Pseudomonas aeruginosa biofilms. Chua SL; Yam JK; Hao P; Adav SS; Salido MM; Liu Y; Givskov M; Sze SK; Tolker-Nielsen T; Yang L Nat Commun; 2016 Feb; 7():10750. PubMed ID: 26892159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]